CSIMarket
 


Biotechnology & Drugs Industry Profitability

Profitability Information & Trends 
  
Industry:   Category:   Period:  

Biotechnology & Drugs Industry Profitability Ratios 4 Q 2020 3 Q 2020 2 Q 2020 1 Q 2020 4 Q 2019
  2020 2020 2020 2020 2019
Gross Margin 71.33 % 72.72 % 73.73 % 80.45 % 77.86 %
Gross Margin Annual (TTM) 72.19 % 75.57 % 76.86 % 79.22 % 78.98 %
Gross Margin Ranking # 20 # 20 # 15 # 12 # 20
EBITDA Margin 16.17 % 30.31 % 5.5 % 24.86 % 47.73 %
EBITDA Margin Annual (TTM) 23.17 % 26.06 % 21.87 % 26.17 % 21.34 %
EBITDA Margin Ranking # 47 # 19 # 71 # 16 # 8
Operating Margin 23.61 % 23.14 % - 21.11 % 15.58 %
Operating Margin Annual (TTM) 20.68 % 17.9 % 13.79 % 16.23 % 9.06 %
Operating Margin Ranking # 24 # 18 # 86 # 14 # 35
Pre-Tax Margin 3.37 % 15.92 % - 15.37 % 14.51 %
Pre-Tax Margin Annual (TTM) 10.27 % 13.13 % 10.1 % 10.65 % 5.46 %
Pre-Tax Margin Ranking # 71 # 25 # 86 # 15 # 24
Net Margin 7.54 % 12.83 % - 19.46 % 15.35 %
Net Margin Annual (TTM) 8.85 % 10.32 % 7.98 % 10.48 % 4.18 %
Net Margin Ranking # 46 # 27 # 94 # 4 # 24


Gross Margin Comment

Biotechnology & Drugs Industry's Revenue increased sequentially by 13.23 % faster than Gross Profit increase of 8.76 %, this led to contraction in Gross Margin to 71.33 %, below Industry average.

On the trailing twelve months basis gross margin in 4 Q 2020 fell to 72.19 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest gross margin. Gross margin total ranking has deteriorated compare to previous quarter from to 20.

Note, forth quarter Numbers include only companies who have reported forth quarter earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
102.36 % 79.71 % 71.39 %
4. quarter 2013   4. quarter 2020

Gross Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 20


Other Gross Margins
Compare Industry's gross margin to Nvda's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Nvda's Suppliers Definiton of Gross Margin

Biotechnology & Drugs Industry EBITDA Margin Statistics

 
EBITDA Margin Statistics
High Average Low
47.73 % 28.06 % -6.51 %
4. quarter 2019   4. quarter 2018

EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector # 4
Overall # 47

EBITDA Margin Comment
Biotechnology & Drugs Industry's Ebitda Margin sequentially deteriorated to 16.17 % due to increase in operating costs and despite Revenue increase of 13.23 %.
Biotechnology & Drugs Industry's Ebitda Margin in 4 Q 2020 was lower than Industry average.

On the trailing twelve months basis Ebitda Margin in 4 Q 2020 fell to 23.17 %.

Within Healthcare sector 3 other industries have achieved higher ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from to 47.

Other EBITDA Margins
Compare Industry's EBITDA margin to Nvda's or S&P Gross profits within Biotechnology & Drugs Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin


Biotechnology & Drugs Industry Operating Margin Statistics

 
Operating Margin Comment
Biotechnology & Drugs Industry increased Operating Margin through reduction in operating costs and despite contraction in Operating Profit by -12.63 % and Revenue 13.23 %. Operating Margin in 4 Q 2020 was 23.61 %, below Industry average.

On the trailing twelve months basis operating margin in 4 Q 2020 grew to 20.68 %.

Within Healthcare sector, Biotechnology & Drugs Industry achieved highest operating margin. Operating margin total ranking has deteriorated compare to previous quarter from to 24.



Operating Margin Statistics
High Average Low
41.3 % 24.97 % -10.83 %
4. quarter 2015   4. quarter 2018

Operating Margin Industry Ranking
Within: No.
Healthcare Sector # 1
Overall # 24

Biotechnology & Drugs Industry Pre-Tax Margin Statistics

 


Pre-Tax Margin Statistics
High Average Low
38.85 % 20.36 % -12.75 %
4. quarter 2015   4. quarter 2018

Pre-Tax Margin Comment
Biotechnology & Drugs Industry's Pre-Tax Margin sequentially deteriorated to 3.37 % due to increase in total costs and despite Revenue increase of 13.23 %.
Biotechnology & Drugs Industry's Pre-Tax Margin in 4 Q 2020 was lower than Industry average.

On the trailing twelve months basis Pre-Tax Margin in 4 Q 2020 fell to 10.27 %.

Within Healthcare sector 5 other industries have achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has deteriorated compare to previous quarter from to 71.
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 71

Pre-Tax Margins
Compare Industry's pre-tax margin to Nvda's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Nvda's Competitors Industry Tax Rate


Biotechnology & Drugs Industry Net Margin Statistics

 





Net Margin Comment
Biotechnology & Drugs Industry's Net Margin sequentially deteriorated to 7.54 % due to increase in total costs and despite Revenue increase of 13.23 %.
Biotechnology & Drugs Industry's Net Margin in 4 Q 2020 was lower than Industry average.

On the trailing twelve months basis Net margin in 4 Q 2020 fell to 8.85 %.

Within Healthcare sector 2 other industries have achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from to 46.

Net Margin Statistics
High Average Low
32.97 % 15.46 % -18.25 %
4. quarter 2015   4. quarter 2017
Net Margin Industry Ranking
Within: No.
Healthcare Sector # 3
Overall # 46

Other Net Margins
Compare Industry's net margin to Nvda's or S&P Net profits within Biotechnology & Drugs Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Nvda's Suppliers Definiton of Net Margin



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GOLF's Profile

Stock Price

GOLF's Financials

Business Description

Fundamentals

Charts & Quotes

GOLF's News

Suppliers

GOLF's Competitors

Customers & Markets

Economic Indicators

GOLF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071